Method for treating systemic lupus erythematosus
AssigneesShanghai Huaota Biopharmaceutical Co., Ltd., Huabo Biopharm (Shanghai) Co., Ltd.
InventorsYifan ZHAN, Yujie FENG, Xiaojuan MA, Xiangyang ZHU
Life of this patent
Estimating the term…
Abstract
The present application relates to the use of a drug combination in the preparation of a drug. The drug is used for preventing and/or treating systemic lupus erythematosus, and the drug combination comprises an antigen binding protein targeting IL-17A and an antigen binding protein targeting IL-36R. The present application further relates to the use of a bispecific antibody targeting IL-17A and targeting IL-36R in the preparation of a drug.
Claims36
-92. (canceled)
A method for preventing and/or treating systemic lupus erythematosus comprising administering a drug to a subject in need thereof, wherein the drug is capable of targeting IL-17A and IL-36R.
-99. (canceled)
-102. (canceled)
-105. (canceled)
(canceled)
-119. (canceled)
-122. (canceled)
(canceled)
-135. (canceled)
-139. (canceled)
-142. (canceled)
-152. (canceled)
-155. (canceled)
-158. (canceled)
-177. (canceled)
-186. (canceled)
Dependencies are inferred from the claim text.